Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (561-570 of 941) with videos related to

Pageof 95
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2015
siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate CancerYoshiaki Yamamoto, Paulo J C Lin, Eliana Beraldi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancerAlan I So, Randy J Levitt, Bernhard Eigl, et al.
The Journal of Biological Chemistry|June 27, 2013
Mutation of the salt bridge-forming residues in the ETV6-SAM domain interface blocks ETV6-NTRK3-induced cellular transformationNaniye Cetinbas, Helen Huang-Hobbs, Cristina Tognon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 17, 2010
Comparison of bifunctional chelates for (64)Cu antibody imagingCara L Ferreira, Donald T T Yapp, Sarah Crisp, et al.
The Prostate|February 24, 2006
Loss of PTEN is associated with progression to androgen independenceJerod Bertram, James W Peacock, Ladan Fazli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2013
The mechanism of DAB2IP in chemoresistance of prostate cancer cellsKaijie Wu, Daxing Xie, Yonglong Zou, et al.
Neoplasia (New York, N.Y.)|December 19, 2015
Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell CarcinomaKyung Seok Han, Peter A Raven, Sebastian Frees, et al.
Physical Chemistry Chemical Physics : PCCP|June 10, 2017
Correction: Dynamic nuclear polarization in a magnetic resonance force microscope experimentCorinne E Isaac, Christine M Gleave, Paméla T Nasr, et al.
EMBO Molecular Medicine|May 21, 2016
Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosisNader Al Nakouzi, Chris Kedong Wang, Eliana Beraldi, et al.
Cold Spring Harbor Molecular Case Studies|September 3, 2017
A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agentsDavid C Wilkes, Verena Sailer, Hui Xue, et al.
Pageof 95

Showing results (561-570 of 941) with videos related to

Sort By:
Pageof 95
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2015
siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate CancerYoshiaki Yamamoto, Paulo J C Lin, Eliana Beraldi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancerAlan I So, Randy J Levitt, Bernhard Eigl, et al.
The Journal of Biological Chemistry|June 27, 2013
Mutation of the salt bridge-forming residues in the ETV6-SAM domain interface blocks ETV6-NTRK3-induced cellular transformationNaniye Cetinbas, Helen Huang-Hobbs, Cristina Tognon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 17, 2010
Comparison of bifunctional chelates for (64)Cu antibody imagingCara L Ferreira, Donald T T Yapp, Sarah Crisp, et al.
The Prostate|February 24, 2006
Loss of PTEN is associated with progression to androgen independenceJerod Bertram, James W Peacock, Ladan Fazli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2013
The mechanism of DAB2IP in chemoresistance of prostate cancer cellsKaijie Wu, Daxing Xie, Yonglong Zou, et al.
Neoplasia (New York, N.Y.)|December 19, 2015
Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell CarcinomaKyung Seok Han, Peter A Raven, Sebastian Frees, et al.
Physical Chemistry Chemical Physics : PCCP|June 10, 2017
Correction: Dynamic nuclear polarization in a magnetic resonance force microscope experimentCorinne E Isaac, Christine M Gleave, Paméla T Nasr, et al.
EMBO Molecular Medicine|May 21, 2016
Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosisNader Al Nakouzi, Chris Kedong Wang, Eliana Beraldi, et al.
Cold Spring Harbor Molecular Case Studies|September 3, 2017
A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agentsDavid C Wilkes, Verena Sailer, Hui Xue, et al.
Pageof 95